Eritoran
Drug profile
Also known as: eritoran sodium, eritoran tetrasodium
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Eritoran is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including TLR4.
- Molecular targets: TLR4 (1 listed in DrugCentral).
- Molecular formula: C66H126N2O19P2; molecular weight 1313.68 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Toll-like receptor 4 | TLR4 | unknown | IC50 8.82 |
Chemical structure
| Molecular formula | C66H126N2O19P2 |
|---|---|
| Molecular weight | 1313.68 g/mol |
| CAS number | 185955-34-4 |
| InChIKey | BPSMYQFMCXXNPC-PFJUCRORSA-N |
| PubChem CID | 6912404 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Eritoran work?
Its molecular targets in DrugCentral include TLR4.
What is the chemical formula of Eritoran?
Eritoran has the molecular formula C66H126N2O19P2 and a molecular weight of 1313.68 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1044 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3301672 — compound record and bioactivity
- PubChem CID 6912404 — chemical identifiers
- DrugBank DB04933 — drug record
- FDA UNII 551541VI0Y — substance identity
- UniProt O00206 (TLR4) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.